173 related articles for article (PubMed ID: 23358114)
1. PIASγ enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy.
Arredondo C; Orellana M; Vecchiola A; Pereira LA; Galdames L; Andrés ME
PLoS One; 2013; 8(1):e55035. PubMed ID: 23358114
[TBL] [Abstract][Full Text] [Related]
2. PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1.
Galleguillos D; Vecchiola A; Fuentealba JA; Ojeda V; Alvarez K; Gómez A; Andrés ME
J Biol Chem; 2004 Jan; 279(3):2005-11. PubMed ID: 14559918
[TBL] [Abstract][Full Text] [Related]
3. Complex regulation of orphan nuclear receptor Nur77 (Nr4a1) transcriptional activity by SUMO2 and PIASγ.
Dodat F; Cotnoir-White D; Dianati E; Vallet A; Mader S; Lévesque D
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118908. PubMed ID: 33189785
[TBL] [Abstract][Full Text] [Related]
4. PIASγ controls stability and facilitates SUMO-2 conjugation to CoREST family of transcriptional co-repressors.
Sáez JE; Arredondo C; Rivera C; Andrés ME
Biochem J; 2018 Apr; 475(8):1441-1454. PubMed ID: 29555846
[TBL] [Abstract][Full Text] [Related]
5. The E3 SUMO ligase PIASγ is a novel interaction partner regulating the activity of diabetes associated hepatocyte nuclear factor-1α.
Kaci A; Keindl M; Solheim MH; Njølstad PR; Bjørkhaug L; Aukrust I
Sci Rep; 2018 Aug; 8(1):12780. PubMed ID: 30143652
[TBL] [Abstract][Full Text] [Related]
6. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
7. Minireview: What is Known about SUMOylation Among NR4A Family Members?
Dodat F; Mader S; Lévesque D
J Mol Biol; 2021 Oct; 433(21):167212. PubMed ID: 34437889
[TBL] [Abstract][Full Text] [Related]
8. Tomosyn interacts with the SUMO E3 ligase PIASγ.
Geerts CJ; Jacobsen L; van de Bospoort R; Verhage M; Groffen AJ
PLoS One; 2014; 9(3):e91697. PubMed ID: 24614299
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1.
de Vera IM; Giri PK; Munoz-Tello P; Brust R; Fuhrmann J; Matta-Camacho E; Shang J; Campbell S; Wilson HD; Granados J; Gardner WJ; Creamer TP; Solt LA; Kojetin DJ
ACS Chem Biol; 2016 Jul; 11(7):1795-9. PubMed ID: 27128111
[TBL] [Abstract][Full Text] [Related]
10. Modification of cardiac transcription factor Gata6 by SUMO.
Chen H; Sun W; Zhu J; Yuan H; Chu M; Wen B
Biochimie; 2020 Mar; 170():212-218. PubMed ID: 32017966
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
Ohshima T; Koga H; Shimotohno K
J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
14. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
16. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
Han X; Wang XL; Li Q; Dong XX; Zhang JS; Yan QC
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1279-90. PubMed ID: 25877955
[TBL] [Abstract][Full Text] [Related]
18. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
19. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
Nishida T; Yasuda H
J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
[TBL] [Abstract][Full Text] [Related]
20. PIAS1 interacts with and represses SOX9 transactivation activity.
Oh HJ; Kido T; Lau YF
Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
